Research team will use the antibodies to study genomic areas in C. elegans and D. melanogaster that control chromosomal functions.

Strategic Diagnostics will provide a scientist at the University of North Carolina-Chapel Hill with an antibody library to aid in his genomic research. Jason Lieb, Ph.D., and his team will use this library, which was produced with SDI’s Genomic Antibody Technology™ (GAT) platform.

In the arrangement, SDI will retain the commercial rights to the antibodies produced and will be the sole commercial distributor to the scientific community through the SDI’s SEQer™ catalog.

These antibodies will be used in his project, which is identifing and characterizing DNA sequence elements and proteins that control genome activity in the Caenorhabditis elegans and Drosophila melanogaster genomes. Studies will focus on those areas of the genome that regulate chromosomal functions such as transcription, DNA replication and repair, recombination, and chromosome segregation.

This work that is part of the National Human Genome Research Institute’s model-organism ENCODE (modENCODE) Project  and sponsored by the NIH.


Previous articleScientists Identify Genes Involved in Earliest Stage of Cancer Development
Next articleRegulus Licenses miRNA Antagonist IP from Stanford University